OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CNTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Context Therapeutics (CNTX) Earnings Date & Reports

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CNTX is expected to report earnings to fall 26.22% to -6 cents per share on November 05

Context Therapeutics CNTX Stock Earnings Reports

Q3'25

Est.

$-0.07

Q2'25

Missed

by $0.03

Q1'25

Beat

by $0.07

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.17

The last earnings report on August 06 showed earnings per share of -9 cents, missing the estimate of -5 cents. With 178.30K shares outstanding, the current market capitalization sits at 70.53M.

View a ticker or compare two or three

Compare

CNTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CNTX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CNTX showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2001 Market Street

Phone

+1 267 225-7416

Employees

Web

https://www.contexttherapeutics.com